A novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway
Abstract Background We have previously demonstrated that ginsenoside compound K can attenuate the formation of atherosclerotic lesions. Therefore, ginsenoside compound K has potential for atherosclerosis therapy. How to improve the druggability and enhance the antiatherosclerotic activity of ginseno...
Saved in:
Main Authors: | Yan Huang (Author), Xiaodong Ran (Author), Hongmei Liu (Author), Mingming Luo (Author), Yiyu Qin (Author), Jinqiong Yan (Author), Xiaohui Li (Author), Yi Jia (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New dammarane-type triterpenoids from hydrolyzate of total Gynostemma pentaphyllum saponins with protein tyrosine phosphatase 1B inhibitory activity
by: Daopeng Tan, et al.
Published: (2023) -
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
by: Emily E. Morin, et al.
Published: (2020) -
Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
by: Sisi Lei, et al.
Published: (2024) -
Dammarane triterpenes targeting α-synuclein: biological activity and evaluation of binding sites by molecular docking
by: Alberto Cornejo, et al.
Published: (2021) -
Sex-related differences of lipid metabolism induced by triptolide: The possible role of the LXRα/SREBP-1 signaling pathway
by: Zhenzhou eJiang, et al.
Published: (2016)